Comparison of governance approaches for the control of antimicrobial resistance: Analysis of three European countries

Antimicrobial Resistance and Infection Control
Gabriel BirgandRaheelah Ahmad

Abstract

Policy makers and governments are calling for coordination to address the crisis emerging from the ineffectiveness of current antibiotics and stagnated pipe-line of new ones - antimicrobial resistance (AMR). Wider contextual drivers and mechanisms are contributing to shifts in governance strategies in health care, but are national health system approaches aligned with strategies required to tackle antimicrobial resistance? This article provides an analysis of governance approaches within healthcare systems including: priority setting, performance monitoring and accountability for AMR prevention in three European countries: England, France and Germany. Advantages and unresolved issues from these different experiences are reported, concluding that mechanisms are needed to support partnerships between healthcare professionals and patients with democratized decision-making and accountability via collaboration. But along with this multi-stakeholder approach to governance, a balance between regulation and persuasion is needed.

References

Aug 25, 2001·Seminars in Respiratory Infections·S L Newman
Mar 1, 1992·Current Biology : CB·U Strähle, P W Ingham
Nov 19, 2005·BMJ : British Medical Journal·Angela Coulter
Jun 20, 2006·Social Science & Medicine·Peter Washer, Helene Joffe
Feb 8, 2008·Nature Medicine·Virginia Hughes
Dec 5, 2008·The Journal of Hospital Infection·Petra GastmeierChristine Geffers
Mar 6, 2010·Forensic Science International : Synergy·John M CorkeryFabrizio Schifano
Jun 17, 2011·The Milbank Quarterly·Mary Dixon-WoodsPeter J Pronovost
Nov 5, 2011·Journal of Medical Systems·Orrin I Franko, Timothy F Tirrell
Jan 24, 2012·Health Policy·Peter C SmithTobechukwu Kene
Nov 13, 2012·American Journal of Disaster Medicine·Lancer A ScottAmy E Wahlquist
Dec 1, 2012·The Journal of Antimicrobial Chemotherapy·Anne CarbonneUNKNOWN MDRB Surveillance National Steering Group (BMR-Raisin)
Mar 31, 2015·Health Economics, Policy, and Law·Sabina NutiMilena Vainieri
Sep 12, 2015·International Journal of Medical Microbiology : IJMM·C SchröderP Gastmeier
Nov 7, 2015·The Journal of Hospital Infection·S HansenUNKNOWN PROHIBIT study group
Dec 17, 2015·Bulletin of the World Health Organization·Steven J HoffmanJohn-Arne Røttingen
Mar 22, 2016·The Journal of Hospital Infection·L BrewsterM Dixon-Woods
May 6, 2016·Lancet·Marisol Touraine
Jun 16, 2017·One Health·Craig Stephen, Barry Stemshorn

❮ Previous
Next ❯

Citations

Jul 18, 2019·The Medical Journal of Australia·Joshua S DavisBenjamin P Howden
Feb 16, 2020·Antimicrobial Resistance and Infection Control·Gabriel BirgandUNKNOWN Percept-R Study Group
Jan 2, 2019·Gut Pathogens·Esther-Maria AntãoLothar H Wieler
Sep 11, 2020·Journal of Public Health Policy·Arne RuckertRonald Labonté
Mar 11, 2021·Infection and Drug Resistance·Elisa GiacominiLuca Degli Esposti
Dec 8, 2020·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·J V Peter
Jul 31, 2021·The Lancet Regional Health. Western Pacific·Alvin Qijia ChuaHelena Legido-Quigley
Oct 8, 2019·The Lancet Infectious Diseases·Michael AndersonElias Mossialos

❮ Previous
Next ❯

Software Mentioned

NewDrugs4BadBugs
AQUA
IQTIG
Propias

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.